Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxford Centre for Diabetes, Endocrinology and Metabolism

OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.

Head of OCDEM

History

Read about the beginnings of our centre.

Find out more

Patient undergoing a DEXA scan

OCDEM is one of the largest dedicated research centres in diabetes, endocrinology and metabolism in Europe.  Led by Professor David Ray, our work spans the spectrum of basic, translational and patient-orientated research. We are closely integrated with excellent clinical care for patients with diabetes, metabolic and endocrine conditions.

Areas of strength

  • Type 2 diabetes including genomics, islet biology and function, novel therapeutics and large-scale clinical trials providing evidence for best practise
  • Human integrative metabolic physiology
  • Endocrine disorders such as glucocorticoid action, pituitary tumours and calcium homeostasis

Research Facilities

The Oxford BioBank is a resource for medical research to translate early discoveries into benefit for patients.

Funders

Our major funders include AstraZeneca, the European Commission, the Medical Research Council, Merck & Co and the Wellcome Trust.